NYSE : AVNS
Avanos Medical, Inc. — Key statistics
Healthcare · Medical Devices · United States
Last price 24.99 USD (At close: Jul 24, 2026) · Market cap 1.17B
Overview · Financial statements · Key statistics · Dividends · Company profile · Price history · Reports
Key statistics
Valuation
| Measure | Value |
|---|
| Market Cap | 1.17B |
| Enterprise Value | 1.24B |
Dates
| Measure | Value |
|---|
| Earnings Date | Aug 4, 2026 |
| Ex-Dividend Date | n/a |
Shares
| Measure | Value |
|---|
| Current Share Class | 46.85M |
| Shares Outstanding | 46.85M |
| Shares Change (YoY) | +0.92% |
| Shares Change (QoQ) | +2.37% |
| Owned by Insiders (%) | 1.66% |
| Owned by Institutions (%) | 92.57% |
| Float | 46.05M |
Ratios
| Measure | Value |
|---|
| PE Ratio | n/a |
| Forward PE | 21.73 |
| PS Ratio | 1.64 |
| Forward PS | 1.63 |
| PB Ratio | 1.49 |
| P/TBV Ratio | 4.28 |
| P/FCF Ratio | 156.10 |
| P/OCF Ratio | 31.90 |
| PEG Ratio | n/a |
Evratios
| Measure | Value |
|---|
| EV / Earnings | n/a |
| EV / Sales | 1.74 |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | 165.80 |
Financialposition
| Measure | Value |
|---|
| Current Ratio | 2.48 |
| Quick Ratio | 1.29 |
| Debt / Equity | 0.18 |
| Debt / EBITDA | n/a |
| Debt / FCF | 18.45 |
| Interest Coverage | -10.35 |
Financialefficiency
| Measure | Value |
|---|
| Return on Equity (ROE) | -9.18% |
| Return on Assets (ROA) | 0.95% |
| Return on Invested Capital (ROIC) | 1.96% |
| Return on Capital Employed (ROCE) | -8.11% |
| Weighted Average Cost of Capital (WACC) | 11.95% |
| Revenue Per Employee | $313,030 |
| Profits Per Employee | -$32,532 |
| Employee Count | 2,287 |
| Asset Turnover | 0.66 |
| Inventory Turnover | 2.56 |
Taxes
| Measure | Value |
|---|
| Income Tax | 6.10M |
| Effective Tax Rate | n/a |
Stockprice
| Measure | Value |
|---|
| Beta (5Y) | 1.57 |
| 52-Week Price Change | +106.36% |
| 50-Day Moving Average | 24.90 |
| 200-Day Moving Average | 16.92 |
| Relative Strength Index (RSI) | 62.10 |
| Average Volume (20 Days) | 767,429 |
Shortselling
| Measure | Value |
|---|
| Short Interest | 1.75M |
| Short Previous Month | 1.71M |
| Short % of Shares Out | 3.74% |
| Short % of Float | 3.80% |
| Short Ratio (days to cover) | 2.05 |
Incomestatement
| Measure | Value |
|---|
| Revenue | 715.90M |
| Gross Profit | 358.30M |
| Operating Income | 16.40M |
| Pretax Income | -68.30M |
| Net Income | -74.40M |
| EBITDA | -35.00M |
| EBIT | -74.50M |
| Loss Per Share | -$1.60 |
Balancesheet
| Measure | Value |
|---|
| Cash & Cash Equivalents | 65.60M |
| Total Debt | 138.40M |
| Net Cash | -72.80M |
| Net Cash Per Share | -$1.55 |
| Equity (Book Value) | 782.10M |
| Book Value Per Share | 16.76 |
| Working Capital | 193.80M |
Cashflow
| Measure | Value |
|---|
| Operating Cash Flow | 36.70M |
| Capital Expenditures | -29.20M |
| Depreciation & Amortization | 39.50M |
| Net Borrowing | -9.40M |
| Free Cash Flow | 7.50M |
| FCF Per Share | $0.16 |
Margins
| Measure | Value |
|---|
| Gross Margin | 50.05% |
| Operating Margin | 2.29% |
| Pretax Margin | -9.54% |
| Profit Margin | -10.39% |
| EBITDA Margin | -4.89% |
| EBIT Margin | -10.41% |
| FCF Margin | 1.05% |
Dividends
| Measure | Value |
|---|
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| FCF Payout Ratio | n/a |
| Buyback Yield | -0.92% |
| Shareholder Yield | -0.92% |
| Earnings Yield | -6.36% |
| FCF Yield | 0.64% |
Analystforecasts
| Measure | Value |
|---|
| Price Target | n/a |
| Price Target Difference | n/a |
| Analyst Consensus | n/a |
| Analyst Count | n/a |
| Revenue Growth Forecast (3Y) | 14.83% |
| EPS Growth Forecast (3Y) | n/a |
Stocksplits
| Measure | Value |
|---|
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
| Measure | Value |
|---|
| Altman Z-Score | 1.2 |
| Piotroski F-Score | 5 |
Fairvalue
| Measure | Value |
|---|
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | n/a |
| Graham Upside | n/a |